Zobrazeno 1 - 10
of 78
pro vyhledávání: '"BC, Breast Cancer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jing Wang, Marcel J.W. Greuter, Karin M. Vermeulen, Frank B. Brokken, Monique D. Dorrius, Wenli Lu, Geertruida H. de Bock
Publikováno v:
Breast, Vol 61, Iss, Pp 58-65 (2022)
The Breast, 61, 58-65. Churchill Livingstone
The Breast : Official Journal of the European Society of Mastology
The Breast, 61, 58-65. Churchill Livingstone
The Breast : Official Journal of the European Society of Mastology
Introduction Magnetic resonance imaging (MRI) has shown the potential to improve the screening effectiveness among women with dense breasts. The introduction of fast abbreviated protocols (AP) makes MRI more feasible to be used in a general populatio
Autor:
Lyndsey Highton, D. Gareth Evans, Ashu Gandhi, James Harvey, Sacha J Howell, Fiona Lalloo, John Murphy, Emma R. Woodward, Anthony Howell, Tara Clancy, Lester Barr, Elaine F. Harkness, Julie Wisely
Publikováno v:
Breast, Vol 60, Iss, Pp 45-52 (2021)
The Breast : Official Journal of the European Society of Mastology
Evans, D G, Gandhi, A, Wisely, J, Clancy, T, Woodward, E, Harvey, J, Highton, L, Murphy, J, Barr, L, Howell, S, Lalloo, F, Harkness, E & Howell, T 2021, ' Uptake of bilateral-risk-reducing-mastectomy : Prospective analysis of 7195 women at high-risk of breast cancer ', The Breast, vol. 60, pp. 45-52 . https://doi.org/10.1016/j.breast.2021.08.015
The Breast : Official Journal of the European Society of Mastology
Evans, D G, Gandhi, A, Wisely, J, Clancy, T, Woodward, E, Harvey, J, Highton, L, Murphy, J, Barr, L, Howell, S, Lalloo, F, Harkness, E & Howell, T 2021, ' Uptake of bilateral-risk-reducing-mastectomy : Prospective analysis of 7195 women at high-risk of breast cancer ', The Breast, vol. 60, pp. 45-52 . https://doi.org/10.1016/j.breast.2021.08.015
Background Bilateral-Risk-Reducing-Mastectomy-(BRRM) is well described in BRCA1/2 pathogenic variant carriers. However, little is known about the relative uptake, time trends or factors influencing uptake in those at increased breast cancer risk not
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 59, Iss, Pp 279-285 (2021)
Breast, Vol 59, Iss, Pp 279-285 (2021)
Purpose High prevalence, unreliable risk discrimination and poor clinical outcomes are observed in malignant and benign breast diseases (BD). The involvement of microbial communities in the development of BD has become topical, and distal influences
Autor:
Hanan E. Al-Rashidi, Dalia T Hussein, Sherif Refaat, Enas Ahmed, Fatma M. El-Tantawy, Sahar Hamed
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)
According Global Cancer Statistics 2020 GLOBOCAN estimates female breast cancer was found as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), and the fourth leading cause (6.9%) of cancer death among women worldwid
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Breast cancer arises as a result of multiple interactions between environmental and genetic factors. Conventionally, breast cancer is treated based on histopathological and clinical features. DNA technologies like the human genome microarray are now
Autor:
Kelly-Anne Phillips, Roger L. Milne, Danielle Mazza, James A. Chamberlain, Courtney Macdonald, kConFab Investigators
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 60, Iss, Pp 35-37 (2021)
Breast, Vol 60, Iss, Pp 35-37 (2021)
Increased implementation of proven prevention strategies is required to combat rising breast cancer incidence. We assessed use of risk reducing medication (RRMed) by Australian women at elevated breast cancer risk. Only 2.4% had ever used RRMed. High
Autor:
Nabil Ahmed, Khaled Sanber, Mohamed Z. Gad, Ahmed Z. Gad, Hafez Mohamed Hafez, Amira Abdel Motaal, Rana Ahmed Youness, Emad Khallaf, Gi-Ja Lee, Yong Jin Ahn
Publikováno v:
Journal of Advanced Research
Journal of Advanced Research, Vol 27, Iss, Pp 177-190 (2021)
Journal of Advanced Research, Vol 27, Iss, Pp 177-190 (2021)
Graphical abstract
Introduction Hydrogen sulphide (H2S) has been established as a key member of the gasotransmitters family that recently showed a pivotal role in various pathological conditions including cancer. Objectives This study investigat
Introduction Hydrogen sulphide (H2S) has been established as a key member of the gasotransmitters family that recently showed a pivotal role in various pathological conditions including cancer. Objectives This study investigat
Autor:
Maxim De Schepper, Edoardo Isnaldi, Gabriele Zoppoli, Denis Larsimont, Fatima Cardoso, Christine Desmedt, Ghizlane Rouas, Elia Biganzoli, Christos Sotiriou, Francois Richard, Sophia Leduc, Marion Maetens, Giuseppe Floris, Tatjana Geukens, Delphine Vincent
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 54, Iss, Pp 179-186 (2020)
Breast, 54
Breast, Vol 54, Iss, Pp 179-186 (2020)
Breast, 54
Adipocytes and cancer-associated adipocytes (CAAs) are poorly investigated cells in the tumor microenvironment. Different image analysis software exist for identifying and measuring these cells using scanned hematoxylin and eosin (H&E)-stained slides
Autor:
Sabine Matou-Nasri, Hala Alajmi, Safia A. Messaoudi, Anuradha Venktraman, Zeyad Alehaideb, Mohammed Syed Ali, Saranya Rameshbabu, Hamad Al-Eidi
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 28, Iss 8, Pp 985-993 (2020)
Saudi Pharmaceutical Journal, Vol 28, Iss 8, Pp 985-993 (2020)
Breast cancer therapy using anticancer bioactive compounds derived from natural products as adjuvant treatment has gained recognition due to expensive and toxic conventional chemotherapeutic drugs. The whole plant of Anastatica hierochuntica (L.) (A.